Pharm - Cognitive Disorders Flashcards
Alzheimer’s Dementia
• May start with mitochondria dysfunction, the change in ATP causes an excessive phosphorylation of the tau protein. Accumulation of Amyloid Beta. The amyloid plaques accumulate and cause an activation of microglia and subsequent release of pro-inflammatory cytokines. The cytokine and inflammatory response causes the death of neuron.
Alzheimer’s Dementia
Agitation / aggression
Atypical anti psychotic drugs (risperidone, lanzepine, quetiapine
Alzheimer’s Dementia
Depression
SSRIs (sertraline, fluoxetine) preferred Tricyclic antidepressants (use with caution)(nortryptyline, tryptyline)
Alzheimer’s Dementia
Psychosis
Hallucinations
Quetiapine, olanzepine, risperidone
Delusions
Atypical anti psychotic drugs
Haloperidol
Haloperidol – a typical antipsychotic, high profile of pyramidal side effects
akinesia
Alzheimer’s Dementia
Sleep disorders
Treated with H1 blockers (promethazine) Sedatives, promethazine etc
Alzheimer’s Dementia
Dimentia
Cholinesterase inhibitors (increase ACh, boosting cholinergic transmission) ONLY MILD TO MODERATE DEMENTIA
Donepezil,(must cross BBB)
Well tolerated
Relatively lower affinity for peripheral cholinesterase
Long plasma T ½ (once a day dosing)
Improves cognition
Cholinergic side effects may appear (diarrhea, nausea and vomiting
Rivastigmine
Effective in patients with mild to moderate AD
Toxicity: Significant nausea vomiting, head aches, anorexia
Must be administered with food
Galatamine Slows the decline in cognition Improves quality of daily activity GI disturbances (anorexia, vomiting nausea diarrhea and weight loss) Effective in mild to moderate AD
Frontotemporal Dementia (FTD)
Focal degeneration of the temporal and frontal lobes
Prevalence: 50 to 60 years,
Abnormalities with 5HT and Dopamine, cholinergic system conserved
Characterize by changes in personality, social behavior or language, progressing to global dementia affecting cognitive domains
Some patients may show extrapyramidal or motor neuron involvement
Abnormal tau or pathologic TDP43 protein aggregation
Frontotemporal Dementia
Treatment
SSRI
sertraline, paroxetine, and fluvoxamine improve anxiety, eating disorders and impulsive repetitive behavior
Anti psychotic agents (only as a last resort)
Atypical anti psychotic agents at low doses
Quetiapine, olanzepine and aripiprazole
Cholinesterase inhibitors (not effective in FTD). Why? The Cholinergic system is spared
Would drugs such as Bapineuzumab (Aβ antibody) be effective in FTD? Why or why not? No because there is no development of amyloid plaque
Lewy Body Dementia
Clinical manifestation
Visual hallucinations
Parkinsonism, Cognitive fluctuations, Dystonia
Sleep disorders, Neuroleptic sensitivity
Lewy Body Dementia
Treatment
Cholinesterase inhibitors
Rivastigmine, donpenzil, galatamine
Atypical anti psychotic drugs
Anti Parkinson’s drugs
Others: REM sleep disorders (Clonzepam, quetiapine)
Vascular Dementia
2nd only to Alzheimer
Characteristics
Large artery infarcts (cortical & sub cortical locations)
Small artery infarctions (exclusively sub cortical esp. to basal ganglia, caudate, thalamus internal capsule)
Chronic ischemia in the periventricular areas
Risk factors: Diabetes, disorders of lipid metabolism
Treatment of dementia
Rivastigmine
Donepezil
Galantamine
Memantine
Treatment of Delirium
Antipsychotics
Benzodiazepines
The most direct cognitive disorders include:
Amnesia
Dementia
Delirium
Attention-deficit/hyperactivity disorder (ADHD)
(Clinical) Manifestations
Inattention, hyperactive, impulsive behavior, seemingly in constant motion
Easily distracted, excessively talkative
Blame it on the mother risk factors:
Risk factors
Maternal drug use during pregnancy (alcohol, smoking)
Premature birth, genetics
Maternal exposure to environmental toxins e.g. poly chlorinated biphenyls (PCPs)